AI assistant
SURMODICS INC — Director's Dealing 2019
Feb 27, 2019
32845_dirs_2019-02-27_70fea9a5-7b56-4654-93a2-6d9eefd20014.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2019-02-25
Reporting Person: Heine Lisa Wipperman (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-25 | Common Stock | S | 2569 | $57.3795 | Disposed | 5772 | Direct |
Footnotes
F1: Reflects the weighted average price of 2,569 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on February 25, 2019 with sale prices ranging from $57.00 to $57.96 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2: The amount beneficially owned includes 3,874 restricted stock units (RSUs) that vest on service-based vesting dates that will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.